Last reviewed · How we verify
Meptin® Swinghaler
Meptin is a beta-2 adrenergic agonist that relaxes airway smooth muscle to improve breathing in respiratory conditions.
Meptin is a beta-2 adrenergic agonist that relaxes airway smooth muscle to improve breathing in respiratory conditions. Used for Asthma, Chronic obstructive pulmonary disease (COPD).
At a glance
| Generic name | Meptin® Swinghaler |
|---|---|
| Also known as | Meptin® Swinghaler®, Procaterol HCL, Ventolin® MDI, Salbutamol sulfate |
| Sponsor | Taiwan Otsuka Pharm. Co., Ltd |
| Drug class | Beta-2 adrenergic agonist (short-acting or long-acting bronchodilator) |
| Target | Beta-2 adrenergic receptor |
| Modality | Small molecule |
| Therapeutic area | Respiratory / Pulmonology |
| Phase | Phase 3 |
Mechanism of action
The drug binds to beta-2 adrenergic receptors on airway smooth muscle cells, triggering intracellular signaling that leads to muscle relaxation and bronchodilation. This increases airway diameter and improves airflow, providing symptomatic relief in obstructive airway diseases. The Swinghaler formulation is an inhalation device designed for convenient drug delivery.
Approved indications
- Asthma
- Chronic obstructive pulmonary disease (COPD)
Common side effects
- Tremor
- Headache
- Palpitations
- Nervousness
- Muscle cramps
Key clinical trials
- A Study to Evaluate the Efficacy and Safety of Meptin® Swinghaler and Berotec N® Metered Aerosol in Mild to Moderate Stable Asthma Patients (PHASE3)
- A Study to Evaluate the Efficacy and Safety of Meptin® Swinghaler® and Ventolin® MDI in Stable Asthma Patients (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Meptin® Swinghaler CI brief — competitive landscape report
- Meptin® Swinghaler updates RSS · CI watch RSS
- Taiwan Otsuka Pharm. Co., Ltd portfolio CI